Survival in all 316 patients with “diagnosis code-based possible malignancy-associated HLH” and a comparison between those diagnosed during the first 11 years of the study and those diagnosed during the remaining 11 years of the study
| Time period . | Probability of survival, % (95% CI) . | ||||
|---|---|---|---|---|---|
| 1 mo . | 2 mo . | 6 mo . | 12 mo . | 24 mo . | |
| 1997-2007 | 52 (40-63)∗ | 45 (32-56) | 35 (24-47) | 29 (19-40) | 21 (12-32) |
| 2008-2018 | 71 (65-76)∗ | 53 (47-60) | 38 (32-44) | 31 (25-37) | 26 (20-31) |
| 1997-2018 | 67 (62-72) | 52 (46-57) | 37 (32-43) | 31 (25-36) | 25 (20-30) |
| Time period . | Probability of survival, % (95% CI) . | ||||
|---|---|---|---|---|---|
| 1 mo . | 2 mo . | 6 mo . | 12 mo . | 24 mo . | |
| 1997-2007 | 52 (40-63)∗ | 45 (32-56) | 35 (24-47) | 29 (19-40) | 21 (12-32) |
| 2008-2018 | 71 (65-76)∗ | 53 (47-60) | 38 (32-44) | 31 (25-37) | 26 (20-31) |
| 1997-2018 | 67 (62-72) | 52 (46-57) | 37 (32-43) | 31 (25-36) | 25 (20-30) |
There is a significant difference between the probability of survival at 1 month after diagnosis between patients diagnosed from 1997 to 2007 and those diagnosed from 2008 to 2018, as the CIs do not overlap.